Common chromosomal fragile site FRA16D tumor suppressor WWOX gene expression and metabolic reprograming in cells

Genes Chromosomes and Cancer

Volumn 52, Issue 9, 2013, Pages 823-831

  Dayan, Sonia ^a   O'Keefe, Louise V ^a   Choo, Amanda ^a   Richards, Robert I ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; OXIDOREDUCTASE; UNCLASSIFIED DRUG; WW DOMAIN CONTAINING OXIDOREDUCTASE;

ARTICLE; CELL METABOLISM; CHROMOSOME FRAGILE SITE; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; GENETIC REGULATION; GENETIC TRANSCRIPTION; GLYCOLYSIS; HUMAN; HUMAN CELL; HYPOXIA; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; STEADY STATE; TUMOR SUPPRESSOR GENE;

CELL HYPOXIA; CHROMOSOME FRAGILE SITES; GALACTOSE; GLYCOLYSIS; HEK293 CELLS; HUMANS; OXIDATIVE PHOSPHORYLATION; OXIDOREDUCTASES; REACTIVE OXYGEN SPECIES; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 84880513475     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22078     Document Type: Article

References (44)

1. Aqeilan RI, Trapasso F, Hussain S, Costinean S, Marshall D, Pekarsky Y, Hagan JP, Zanesi N, Kaou M, Stein GS, Lian JB, Croce CM. 2007. Targeted deletion of Wwox reveals a tumor suppressor function. Proc Natl Acad Sci U S A 104:3949-3954.
2. Aqeilan RI, Hassan MQ, de Bruin A, Hagan JP, Volinia S, Palumbo T, Hussain S, Lee SH, Gaur T, Stein GS, Lian JB, Croce CM. 2008. The WWOX tumor suppressor is essential for postnatal survival and normal bone metabolism. J Biol Chem 283:21629-21639.
3. Aqeilan RI, Hagan JP, de Bruin A, Rawahneh M, Salah Z, Gaudio E, Siddiqui H, Volinia S, Alder H, Lian JB, Stein GS, Croce CM. 2009. Targeted ablation of the WW domain-containing oxidoreductase tumor suppressor leads to impaired steroidogenesis. Endocrinology 150:1530-1535.
4. Bednarek AK, Keck-Waggoner CL, Daniel RL, Laflin KJ, Bergsagel PL, Kiguchi K, Brenner AJ, Aldaz CM. 2001. WWOX, the FRA16D gene, behaves as a suppressor of tumor growth. Cancer Res 61:8068-8073.
5. Berger R, Bloomfield CD, Sutherland, GR. 1985. Report of the committee on chromosome rearrangements in neoplasia and on fragile sites, Cytogenet Cell Genet 40:490-535.
6. Bignell GR, Greenman CD, Davies H, Butler AP, Edkins S, Andrews JM, Buck G, Chen L, Beare D, Latimer C, Widaa S, Hinton J, Fahey C, Fu B, Swamy S, Dalgliesh GL, Teh BT, Deloukas P, Yang F, Campbell PJ, Futreal PA, Stratton MR. 2010.Signatures of mutation and selection in the cancer genome. Nature 463:893-898.
7. Bonnet S, Archer SL, Allalunis-Turner J, Haromy A, Beaulieu C, Thompson R, Lee CT, Lopaschuk GD, Puttagunta L, Bonnet S, Harry G, Hashimoto K, Porter CJ, Andrade MA, Thebaud B, Michelakis ED. 2007. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 11:37-51.
8. Casper AM, Nghiem P, Arlt MF, Glover TW. 2002. ATR regulates fragile site stability. Cell 111:779-789.
9. Chance B, Hollunger G. 1961. The interaction of energy and electron transfer reactions in mitochondria. I. General properties and nature of the products of succinate-linked reduction of pyridine nucleotide. J Biol Chem 236:1534-1543.
10. Debatisse M, Le Tallec B, Letessier A, Dutrillaux D, Brison O. 2012. Common fragile sites: Mechanisms of instability revisited. Trends Genet 28:22-32.
11. Demirhan O, Tastemir D. 2008. Cytogenetic effects of ethanol on chronic alcohol users. Alcohol Alcohol 43:127-136.
12. Driouch K, Prydz H, Monese R, Johansen H, Lidereau R, Frengen E. 2002. Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors. Oncogene 21:1832-1840.
13. Finnis M, Dayan S, Hobson L, Chenevix-Trench G, Friend K, Ried K, Venter D, Woollatt E, Baker E, Richards RI. 2005. Common chromosomal fragile site FRA16D mutation in cancer cells. Hum Mol Genet 14:1341-1349.
14. Gambhir SS. 2002. Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2:683-693.
15. Glover TW, Coyle-Morris J, Morgan R. 1986. Fragile sites: overview, occurrence in acute nonlymphocytic leukemia and effects of caffeine on expression. Cancer Genet Cytogenet 19:141-150.
16. Glover TW, Hoge AW, Miller DE, Ascara-Wilke JE, Adam AN, Dagenais SL, Wilke CM, Dierick HA, Beer DG. 1998. The murine Fhit gene is highly similar to its human orthologue and maps to a common fragile siteregion. Cancer Res 58:3409-3414.
17. Gohil VM, Sheth SA, Nilsson R, Wojtovich AP, Lee JH, Perocchi F, Chen W, Clish CB, Ayata C, Brookes PS, Mootha VK. 2010. Nutrient-sensitized screening for drugs that shift energy metabolism from mitochondrial respiration to glycolysis. Nat Biotechnol 28:249-255.
18. Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: The next generation. Cell 144:646-674.
19. Krummel KA, Denison SR, Calhoun E, Phillips LA, Smith DI. 2002. The common fragile site FRA16D and its associated gene WWOX are highly conserved in the mouse at Fra8E1. Genes Chromosomes Cancer 34:154-167.
20. Lee JC, Weissglas-Volkov D, Kyttälä M, Dastani Z, Cantor RM, Sobel EM, Plaisier CL, Engert JC, van Greevenbroek MM, Kane JP, Malloy MJ, Pullinger CR, Huertas-Vazquez A, Aguilar-Salinas CA, Tusie-Luna T, de Bruin TW, Aouizerat BE, van der Kallen CC, Croce CM, Aqeilan RI, Marcil M, Viikari JS, Lehtimäki T, Raitakari OT, Kuusisto J, Laakso M, Taskinen MR, Genest J, Pajukanta P. 2008. WW-domain-containing oxidoreductase is associated with low plasma HDL-C levels. Am J Hum Genet 83:180-192.
21. Ludes-Meyers JH, Kil H, Parker-Thornburg J, Kusewitt DF, Bedford MT, Aldaz CM. 2009. Generation and characterization of mice carrying a conditional allele of the Wwox tumor suppressor gene. PLoS One 4:e7775.
22. Marroquin, LD, Hynes J, Dykens JA, Jamieson JD, Will Y. 2007. Circumventing the Crabtree effect: Replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants. Toxicol Sci 97:539-547.
23. Michelakis ED, Sutendra G, Dromparis P, Webster L, Haromy A, Niven E, Maguire C, Gammer TL, Mackey JR, Fulton D, Abdulkarim B, McMurtry MS, Petruk KC. 2010. Metabolic modulation of glioblastoma with dichloroacetate. Sci Transl Med 2:31-34.
24. Mrasek K, Schoder C, Teichmann AC, Behr K, Franze B, Wilhelm K, Blaurock N, Claussen U, Liehr T, Weise A. 2010. Global screening and extended nomenclature for 230 aphidicolin-inducible fragile sites, including 61 yet unreported ones. Int J Oncol. 36:929-940.
25. O'Keefe LV, Richards RI. 2006. Common chromosomal fragile sites and cancer: focus on FRA16D. Cancer Lett 232:37-47.
26. O'Keefe LV, Colella A, Dayan S, Chen Q, Choo A, Jacob R, Price G, Venter D, Richards RI. 2011. Drosophila orthologue of WWOX, the chromosomal fragile site FRA16D tumour suppressor gene, functions in aerobic metabolism and regulates reactive oxygen species. Hum Mol Genet 20:497-509.
27. Palacino JJ, Sagi D, Goldberg MS, Krauss S, Motz C, Wacker M, Klose J, Shen J. 2004. Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J Biol Chem 279:18614-18622.
28. Park SW, Ludes-Meyers J, Zimonjic DB, Durkin ME, Popescu NC, Aldaz CM. 2004. Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma. Br J Cancer 91:753-759.
29. Porporato PE, Dhup S, Dadhich RK, Copetti T, Sonveaux P. 2011. Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review. Front Pharmacol 2:1-18.
30. Richards RI, 2001. Fragile and unstable chromosomes in cancer: causes and consequences. Trends Genet 17:339-345.
31. Ried K, Finnis M, Hobson L, Mangelsdorf M, Dayan S, Nancarrow JK, Woollatt E, Kremmidiotis G, Gardner A, Venter D, Baker E, Richards RI. 2000. Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells. Hum Mol Genet 9:1651-1663.
32. Rodríguez-Enríquez S, Gallardo-Pérez JC, Avilés-Salas A, Marín-Hernández A, Carreño-Fuentes L, Maldonado-Lagunas V, Moreno-Sánchez R. 2008. Energy metabolism transition in multi-cellular human tumor spheroids. J Cell Physiol 216:189-197.
33. Rozier L, El-Achkar E, Apiou F, Debatisse M. 2004. Characterisation of a conserved aphidicolin-sensitive common fragile site at human 4q22 and mouse 6C1: possible association with inherited disease and cancer. Oncogene 23:6872-6880.
34. Schwartz M, Zlotorynski E, Kerem B. 2006. The molecular basis of common and rare fragile sites. Cancer Lett 232:13-26.
35. Siprashvili Z, Sozzi G, Barnes LD, McCue P, Robinson AK, Eryomin V, Sard L, Tagliabue E, Greco A, Fusetti L, Schwartz G, Pierotti MA, Croce CM, Huebner K. 1997. Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc Natl Acad Sci U S A 94:13771-13776.
36. Sottnik JL, Lori JC, Rose BJ, Thamm DH 2011. Glycolysis inhibition by 2-deoxy-D: -glucose reverts the metastatic phenotype in vitro and in vivo. Clin Exp Metastasis 28:865-875.
37. Stein CK, Glover TW, Palmer JL, Glisson BS. 2002. Direct correlation between FRA3B expression and cigarette smoking. Genes Chromosomes Cancer 34:333-340.
38. Suzuki H, Katayama K, Takenaka M, Amakasu K, Saito K, Suzuki K. 2009. A spontaneous mutation of the Wwox gene and audiogenic seizures in rats with lethal dwarfism and epilepsy. Genes Brain Behav 8:650-660.
39. Vogel MW, Fan H, Sydnor J, Guidetti P. 2001. Cytochrome oxidase activity is increased in +/Lc Purkinje cells destined to die. Neuroreport 12:3039-3043.
40. Warburg O, Wind F, Negelein E. 1927. The Metabolism of Tumors in the Body. J Gen Physiol 8:519-530.
41. White FC, Carroll SM, Kamps MP. 1995. VEGF mRNA is reversibly stabilized by hypoxia and persistently stabilized in VEGF-overexpressing human tumor cell lines. Growth Factors 12:289-301.
42. White S, Hewitt J, Turbitt E, van der Zwan Y, Hersmus R, Drop S, Koopman P, Harley V, Cools M, Looijenga L, Sinclair A. 2011. A multi-exon deletion within WWOX is associated with a 46, XY disorder of sex development. Eur J Hum Genet 20:348-351.
43. Yunis JJ, Soreng AL. 1984. Constitutive fragile sites and cancer. Science 226:1199-1204.
44. Zelazowski MJ, Płuciennik E, Pasz-Walczak G, Potemski P, Kordek R, Bednarek AK. 2011. WWOX expression in colorectal cancer-A real-time quantitative RT-PCR study. Tumour Biol 32:551-560.